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Abstract
Testosterone acetate thiosemicarbazone (TATSC, 17-13-hydroxyandrost-4-one acetate thiosemicarbazone)
was synthesized and characterized by single crystal X-ray structure determination. The copper and platinum
complexes of this steroid derivative were synthesized and characterized by spectroscopy and electrochemiatry.
The in vitro activity of these compounds against human breast cancer cell line MCF-7 was tested. The
highest activity was found for the [Pt(TATSC)CI2] followed by [Cu(TATSC)CI2] and the ligand in
compariosn with cisplatin.
Introduction
Transporting a cytotoxic drug selectively to the malignant cells without damaging the cells of the host
organism is the desirable goal in the drug design for anticancer therapy. This task is made difficult because the
morphological and biochemical differences between the malignant and normal cells are often minute. However,
the presence of steroid hormone receptors found in high concentration in malignant cells of breast, ovary and
prostate than in most ofthe normal cells offer excellent olportunities for such selective targeting by attaching a
cytotoxic drug to the receptor binding carrier molecules. The cytotoxic agents that have so far been linked in
such a manner include nitrosoureas,
24 nitrogen mustards,
2’5 epoxides, aziridines, DNA intercalators and
platinum complexes.
6"!3
In the present paper we report the synthesis and molecular structure ofnew steroidal cisplatin conjufates and
a preliminary evaluation of their antiproliferative activity against human breast cancer cell line, viz. MCF-7.
Experimental
All the chemicals used in the synthesis of ligand and its metal complexes were ofAR grade. Solvents used
in the synthesis and spectroscopic studies were distilled prior to their use.
Testosterone acetate (Sigma Chemicals), K2PtCI4 (John Baker, USA), CuCI2.2H20 (Qualigens),
thiosemicarbazide (CDH) were used as supplied. Cisplatin was a gift from Dr. Kasabekar. Thiosemicarbazide
hydrochloride was prepared by adding ml of concentrated hydrochloric acid to a slurry of 1.1 g of powdered
thiosemicarbazide in ethanol. The white precipitate was isolated by filtration with adequate washings with
cold ethanol and water to remove excess acid. It was recrystallized from water and used after drying in vacuum
at room temperature.
Testosteroneacetate thiosemicarbazone (TATSC)
For the synthesis of the thiosemicarbazone ligand, 1.0 g of testosterone acetate (TA) was dissolved in
acetone to which was added 0.39 g TSC.HCI in a 1" molar ratio dissolved in minimum amount of distilled
water. The resulting reaction mixture was heated at 60C with constant stirring for 6-8 hr during which the
colour of the mixture changed from colourless to intense yellow. After completion of the reaction the solvent
was stripped off on the rotavapor till yellow crystalline TATSC separated out. It was washed with cold water
and dried in vacuum. All attempts to grow crystals suitable for single crystal X-ray structure determination
via a normal diffractometer were unsuccessful. A crystal suitable for X-ray diffraction studies via high intensity
synchrotron radiation was grown as pale yellow plate grown from acetonitrile solvent by slow evaporation.
Metal Complexes
These were prepared by reacting the ligand TATSC and corresponding metal chlorides in a 1:1 molar
ratio in acetonitrile solvent at 40C with constant stirring for 8 hr. K2PtCI4 was used as the satrting material
in the synthesis of the platinum complex whereas the copper complex was synthesized using CuCI.2H20.
Instruments:
Elemental analyses were carried out in the Microanalytical Laboratories of the Universities of Pune and
Hull. The magnetic susceptibilities of the metal complexes were measured at 300K on a Faraday Balance. IR
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spectra were recorded as KBr discs in the range 4500 450 cm on a Perkin-Elmer-1615 FTIR
spectrophotometer. Electronic spectra were recorded on a Genesys-2 UV-VIS-NIR spectrophotometer in the
range 200-1100 nm. Cyclic voltammetric (CV) measurements were made in acetonitrile solvent on a
BioAnalytical System BAS CV-27 with XY-recorder using Pt as working electrode against SCE and a Pt
wire as an auxiliary electrode with tetraethylammonium perchlorate (TEAP) as a supporting electrolyte.
X-ray crystal structure determination"
The measurements were made on a Bruker AXS SMART CCD area detector diffractometer at Station 9.8
of the CLRC Daresbury Laboratory synchrotron radiation source.
4 The data was collected
5 at 150K using o
rotation scans with narrow frames and a wavelength of 0.6849 on a yellow crystal of TATSC, C22H32N302S
dimension 0.16 x 0.10 x 0.02 mm. A least squares refinement of the data gave an orthorhombic cell of
TATSC. Full-matrix least-squares refinement of the setting angles Y3ielded a orthorhombic cell with a
8.0940(6) A, b 8.1463(6) A,,c 33.100(3) A, V 2182.5(3) A. For Z 4 and F.W. 402.57, the
calculated density is 1.225 g/cm. Based on systematic absences, packing considerations, statistical analysis
of intensity distribution and the solution and refinement of structures, the space group was determined to be
P21212. Of the 15118 reflections collected, 4276 are unique (Rin 0.898). Table 3 shows a summary of
crystal data and X-ray analysis information for TATSC and the selected bond lengths and bond angles are
listed in Table 4.
The structure was solved by direct methods.
16 Hydrogen atoms showed clearly on difference Fourier maps.
These were geometrically placed and fixed. The non-hydrogen atoms were refined anisotropically. Neutral
atom scattering factors were taken from Cromer and Waber. Full-matrix lwast-squares refinements
6.18 gave
weighted and unweighted agreement factors ofR 0.0742, wR2 0.1550 (for all data above I>2) and Rl
0.1110, wR2 0.1716 (for all data) respectively.
Anticancer Activity Assay
The MCF-7 human breast adinocarcinoma cell line was obtained from the National Centre for Cell Science
(NCCS), Pune. The cells were cultured as monolayers and maintained in a growth medium (Eagles’
Minimum Essential Medium (MEM(E))) consisting of MEM(E) supplemented with 10% FCS, 50g/ml
streptomycin and 50 lag/ml glutamin. Stock cultures were harvested from 25 cm disposable tissue culture
treated flasks and maintained in the incubator with a constant humidified atmosphere of5% CO2 and 95% air
at 37C.
The stock solutions of TATSC and its copper and platinum complexes were prepared as lmg/ml
solutions in DMSO, filtered through 0.22 lam filters and stored in bottles at 8C. The 0.5 mg/ml stock
solution of cisplatin was made in normal saline, filtered and stored at 8C. A neutral red solution was
prepared by dissolving mg neutral red (NR) in 20 ml of MEM(E), warmed and centrifuged at 90 g for 10
rain for removing any neutral red crystals before filtration. De-staining solution was prepared with 1% acetic
acid, 50% ethanol and 49% distilled water v/v according to an established protocol.
9 A Spectrochem-250
ELISA reader was used to read the final absorbances.
Before performing the neutral red assay, a preliminary range finding analysis ofthe potential toxicity of the
test compounds was conducted wherein the highest tolerated dose (HTD) was defined as the highest
concentration of the compound that is tolerated by the cells with minimal alterations in the morphology. For
this analysis, the cells were seeded in 24-well plate at a density of 2 x 105 cells/ml. After 24 hr incubation,
100 1 of the medium was removed from each well except control and to each sample (in triplicate), 100 tl of
the test compound (at different concentrations) was added. Quantitation of the viable cells was carried out by
direct counting with a hemocytometer using trypan blue after 24 and 48 hours.
Since the active compounds were cytotoxic even at the concentration of 0.1 mg/ml, a much lower
concentrationrgange was explored and the cell viability was determined by a neutral red assay using a 96 well
plate method.
Results and Discussion
The analytical data including elemental analyses, electronic transitions and redox potentials of the
complexes is given in Table 1. All the complexes are found to be diamagnetic at room temperature.
The assignment of the significant vibrational bands of the ligand and its metal complexes are reported in
Table 2. The IR spectrum of testosterone acetate thiosemicarbazone (TATSC) exhibits absorption bands at
3425 and 3245 cm due to symmetric and asymmetric v(NH) stretching vibrations which are shifted to the
higher frequency side on metal complexation. The C(3) C=O frequency in TA was replaced by C=N on
condensation with thiosemicarbazone pharmacophore. Other absorptions which are affected upon complex
formation include those due to v(N-N) stretch at 1053 cm and the v(C=N) stretch at 1587 cm
t indicating the
involvement of the azomethine nitrogen in metal coordination. The assignment of the bands involving the
C=S group is uncertain and difficult due to its mixing with other frequencies over a wide range (1300-700
-I -2021 cm ). Unaltered frequencies on complexaton are assigned to the methyl group (carbon portion) of the
steroidal nucleus (2920 cm and the acetate group at C-17 position (1730 cm) respectively.
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Table 1. Analytical data on [Cu(TATSC)CI2] and [Pt(TATSC)CI2] including elemental analyses,
electronic transitions and redox potentials.
Compound Elemental Analysis
%C %H %M
TATSC 64.76 8.38
(65.50) (8.25)
[Cu(TATSC)CI2] 42.54 5.88 10.66
(42.98) (5.75) (11.07)
[Pt(TATSC)CI2] 39.11 4.78 28.90
t39.42t (4.82)t29.58
Electronic Spectra E,2" (MV)+ cm M+/
27932, 25000, 24096
22471, 23474, 25000,
19153, 15432
28571, 25974, 22222,
20202, 19047
aIn DMSO; Parentheses show calculated values; L ligand based peaks
+0.18
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N(3) N(2)
N(1)
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C(3)
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C(17)
0(1)
C(16)
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0(2)
Figure 1. ORTEP plot ofATSC. Hydrogen atoms are not shown.
The copper complex shows bands at 15432 and 19153 cm due to d-d transitions assigned to dy--)dz2 and
dy--)dxz respectively. The bands corresponding to LMCT are observed at 22471, 23474 and 25000 cm. The
platinum complex shows bands at 20202 and 19047 cm
1 assigned to 1Ag--3A2. A broad band at 22222 cm
in this compound may be due to mixin of d-d and CT bands. Two ligand-based peaks are also observed for
this compound at 28571 and 25974 cm" respectively.
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Table 2. Significant IR bands ofTATSC and,, its metal complexes*
Compound v(CH3COO) v(C-O) v(-NH)
Sym.
As’m.
TA 1700 1669
v(C=N) v(C=S) v(N-N)
TATSC 1729 3425 3245 1587 956 1053
[Cu(TATSC)CI2] 1732 3342 3200 1540 1047
[Pt(TATSC)CI.,] 1714 3336
*All values in cm" TA Testosterone acetate
3228 1556 1045
Table gives the cyclic voltammetric data on the ligand and its complexes in acetonitrile using 0.1 M
TEAP vs SCE at 100 mV/s. The CV profile of the ligand in acetonitrile exhibits a broad, irreversible peak at
-1.05 V with no anodic counterpart which can be attributed to the reduction of C=S (thione)
22 chromophore.
On complexation with copper a reversible peak centered at /0.18 V can be seen which is due to CuE+/Cu+
redox couple. An additional irreversible peak observed at -0.77 V is assignable to the ligand. The shifted
ligand potential on complexation indicates easier reduction of the C-S moiety. In the platinum complex no
metal-based peak is observed but an irreversible peak at -0.98 due to the ligand reduction can be seen.
A perspective view ofTATSC is shown in Figure 1. Crystallographic details of the two compounds are
given in Table 3 while selected bond distances and bond angles are listed in Table 4.
Formula
M
Crystal system
Space group
b/A
O:/
y/
Z
V/A
"s
tcac/Cm"
De/gcm
F(000)
Crystal dimensions/mm
Radiation (,/A)
t9 range for data collection/
Scan mode
hkl ranges
Reflections collected
Independent reflections
Ref’mement method
R(F)
wR(F)
Largest difference peak and hole/As
Table, 3. Data collection, parameters for TATSC
TATSC (C22H32N302S)
402.57
Orthorhombic
P212121
8.0940(6)
8.1463(6)
33.100(3)
9O
90
90
4
2182.5(3)
0.017
1.225
868
0.16 x 0.10 x 0.02
0.6849
2.48 to 25
o rotations with narrow range
-9 to 9; -9 to 10; -36 to 40
15118
4276 (R,t 0.0898)
Full-matrix least-squares on F
0.1110
0.1716
0.544 and-0.250
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Table 4. Interatomic distances tat and bond anles o)in TATSC
Distances Angstrom
C(3) N(1) 1.302(5) N(l) N(2) 1.376(5)
N(2) C(20) 1.296(5) C(20)- S(I) 1.672(4)
C(20) N(3) 1.356(5)
Angles/Degree
C(2) C(3) N(1)
C(3) N(1) N(2)
125.8(4)
119.1(3)
115.5(4)
117.0(3)
N(2) C(20)- S(I)
N(1) N(2) C(20)
It can be seen from the structure of TATSC that the molecule crystallizes as the E isomer with the N(2)
litrogen and S(1) sulfur on one side of the C(20)-N(2) bond. The packing diagram shows no intermolecular
hydrogen bonding contacts.
A comparison of the bond distances with other E isomers including 4N-substituted formyl- and
acetylpyridine thiosemicarbazones and ct-ketobutyric acid thiosemicarbazone shows that in the present
compound the C(3)-N(1) bond is slightly longer (0.02 A) while C(20)-S(1) distance is shorter by 0.23 A
which probably results in a stronger C(20)-N(2) bond. The N(1)-N(2) bond is the longest observed than in
any TSC ligand. The bond angle C(20)-N(2,)-N(I) is smaller (117.0) than other E isomers although it is
smaller when compared with the Z isomers. The bond angles C(3)-N(1)-N(2) (115.5) and N(2)-C(20)-S(1)
(119.1(3)) are comparable with those observed in other E isomers. The observation that metal complexation
results in the transformation of the E isomer into the Z configuration with enhanced biological activity suggest
that suchEZ conversion might be crucial for the biological effects of the thiosemicarbazone ligands.
All the synthesized compounds were tested on human breast cancer cell line, MCF-7 which showed
comparable cytotoxicity at identical concentration (Figure 2) as the standard cisplatin compound.
2O
10
0
0.3
Concentration (rnglml)
D Control D DMSO TATSC PtTATSC CuTATSC Cisplatin
Figure 2. Concentration dependent growth inhibition ofMCF-7 (Human Breast Cancer Cell Line)
For the TATSC ligand an increase in the cytotoxicity was observed on metal complexation which can be
explained on the basis of conversion to the preferred Z configuration. Thiosemicarbazone pharmacophores are
known to inhibit DNA synthesis via inhibition of the enzyme RDR and to inflict DNA damages. These
aspects are under investigation presently.
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